Solution Architect
GlaxoSmithKline22 hours ago
London, United KingdomSenior
Responsibilities
- Design end-to-end solution architectures for Finance, HR, Procurement, Legal, and Corporate Affairs initiatives.
- Translate business and non-functional requirements into architecture artifacts including logical designs, integration diagrams, data flows, deployment views, and operational views.
- Design secure, reliable, auditable integrations, APIs, middleware patterns, and data models across corporate platforms and enterprise domains.
- Align solutions with Workday, SAP, strategic platforms, enterprise architecture standards, and corporate functions guardrails.
- Embed security, privacy, compliance, controls, auditability, resilience, monitoring, and recovery considerations into solution designs.
- Provide architecture reviews, design sign-off input, build alignment checks, and guidance to delivery teams throughout the implementation lifecycle.
- Drive reuse of reference patterns, shared services, and integration standards while reducing duplication, tool sprawl, customization, and technical debt.
- Collaborate with Product, Engineering, Data, Security, Delivery, platform owners, and subject-matter experts.
Requirements
- Demonstrated experience as a Solution Architect in digital or technology environments with hands-on system design capability.
- Proven ability to translate business requirements into implementable solution architectures and guide delivery teams through implementation governance.
- Strong understanding of enterprise integration patterns, APIs, and data flows.
- Experience embedding security, privacy, compliance, and operational controls into solution designs.
- Preferred: experience architecting solutions in Finance, HR, Procurement, Legal, or Corporate Affairs domains.
- Preferred: experience working with strategic enterprise platforms, standards-first approaches, and architecture governance models at scale.
Categories
Solutions Engineering
About GlaxoSmithKline
GlaxoSmithKline (GSK) develops and manufactures prescription medicines and vaccines for infectious disease, HIV, respiratory, oncology and immunology, selling to healthcare systems and distributors worldwide. The London‑headquartered public company was formed in 2000 from the merger of Glaxo Wellcome and SmithKline Beecham, and in 2022 spun off its consumer health business as Haleon. GSK’s revenue comes primarily from proprietary drug and vaccine sales supported by global R&D and commercial partnerships.